Fractures and survival in multiple myeloma: results from a population-based study
- PMID: 31792034
- PMCID: PMC7109735
- DOI: 10.3324/haematol.2019.230011
Fractures and survival in multiple myeloma: results from a population-based study
Abstract
Multiple myeloma causes lytic bone lesions and fractures. The impact of fractures on multiple myeloma (MM) survival is unclear. The aim of this study was to evaluate the effect of fractures on survival in MM using data from MM patients diagnosed in Sweden in the years 1990-2013, identified from the Swedish Cancer Registry. Information on date of birth, MM diagnosis, fractures, and death was collected from central registries. A Cox regression model was used to compare survival in patients with and without a fracture at MM diagnosis and another Cox model was used with fracture as a time-dependent variable to assess the effect of fracture on survival after MM diagnosis. Results were adjusted for age, sex, year of diagnosis, and previous fractures. A total of 14,013 patients were diagnosed with MM during the study, of whom 1,213 (8.7%) were diagnosed with a fracture at MM diagnosis, and 3,235 (23.1%) after diagnosis. Patients with a fracture at diagnosis were at a significantly increased risk of death (hazard ratio=1.28; 95% confidence interval: 1.19-1.37). The risk of death was significantly increased in patients with a fracture after MM diagnosis (2.00; 1.90-2.10). The impact of fractures on survival did not change significantly between the two calendar periods 1990-1999 and 2000-2013 (0.98; 0.89-1.08). Our large study shows that MM patients with fractures are at a significantly increased risk of dying compared to those without fractures, which stresses the importance of preventing bone disease in MM.
Copyright© 2020 Ferrata Storti Foundation.
Figures




Comment in
-
Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment.Haematologica. 2020 Apr;105(4):859-861. doi: 10.3324/haematol.2019.245423. Haematologica. 2020. PMID: 32238466 Free PMC article. No abstract available.
Similar articles
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Fracture risk with multiple myeloma: a population-based study.J Bone Miner Res. 2005 Mar;20(3):487-93. doi: 10.1359/JBMR.041131. Epub 2004 Nov 29. J Bone Miner Res. 2005. PMID: 15746994
-
Metabolic bone disease risk factors strongly contributing to long bone and rib fractures during early infancy: A population register study.PLoS One. 2018 Dec 19;13(12):e0208033. doi: 10.1371/journal.pone.0208033. eCollection 2018. PLoS One. 2018. PMID: 30566429 Free PMC article.
-
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.JAMA Oncol. 2015 May;1(2):168-74. doi: 10.1001/jamaoncol.2015.23. JAMA Oncol. 2015. PMID: 26181017
-
Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis.Joint Bone Spine. 2010 Mar;77(2):120-4. doi: 10.1016/j.jbspin.2009.12.002. Epub 2010 Jan 25. Joint Bone Spine. 2010. PMID: 20097594 Review.
Cited by
-
Atypical Presentation of Multiple Myeloma Affecting Appendicular Skeleton Associated with Pathological Neck of Femur and Proximal Humerus Fractures - A Case Report.J Orthop Case Rep. 2024 Aug;14(8):174-178. doi: 10.13107/jocr.2024.v14.i08.4690. J Orthop Case Rep. 2024. PMID: 39157502 Free PMC article.
-
First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis.Hematol Rep. 2024 Aug 6;16(3):529-540. doi: 10.3390/hematolrep16030051. Hematol Rep. 2024. PMID: 39189247 Free PMC article.
-
Proximal femoral multiple myeloma pathological fractures, impending and actual fractures - a patient survival study.BMC Cancer. 2024 Jul 30;24(1):917. doi: 10.1186/s12885-024-12681-0. BMC Cancer. 2024. PMID: 39080587 Free PMC article.
-
Management of Multiple Myeloma: A Review for General Practitioners in Oncology.Curr Oncol. 2023 Apr 22;30(5):4382-4401. doi: 10.3390/curroncol30050334. Curr Oncol. 2023. PMID: 37232792 Free PMC article. Review.
-
Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment.Haematologica. 2020 Apr;105(4):859-861. doi: 10.3324/haematol.2019.245423. Haematologica. 2020. PMID: 32238466 Free PMC article. No abstract available.
References
-
- Swerdlow S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol 2 Revised 4th Edition ed. Lyon, France: IARC; 2016.
-
- Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–548. - PubMed
-
- Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33. - PubMed
-
- Melton LJ, 3rd, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res. 2005;20(3):487–493. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical